Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Mirion Technologies (MIR) through the VizualStocks API.
Mirion’s earnings before interest, taxes, depreciation and amortization, adjusted for stock compensation, foreign exchange, warrant remeasurement, purchase accounting, impairment and issuer-designated non-operating costs as applicable. Each period follows the issuer’s published reconciliation.
adjustedEbitdaRevenue attributed to Mirion sales sites in Asia Pacific. Geography follows the originating site rather than the customer’s delivery location.
asiaPacificRevenueRevenue from Mirion Medical cancer care products, including radiation oncology quality assurance, diagnostic imaging and radiation therapy safety solutions, and nuclear medicine equipment. The current product categories have issuer-recast annual history from 2022 and quarterly history from 2024.
cancerCareRevenueRevenue attributed to Mirion sales sites in Europe. Geography follows the originating site rather than the customer’s delivery location.
europeRevenueRevenue from Mirion Nuclear & Safety products sold into laboratory and research applications, including radiation measurement and personal detection for safety and security requirements.
labsResearchRevenueOperating income or loss of Mirion Medical used by management to evaluate the segment, including depreciation, amortization and applicable segment charges. Corporate costs and financing, tax and other non-operating items are excluded; historical comparisons use issuer-recast allocations.
medicalOperatingIncomeRevenue from Mirion Medical products outside cancer care, including occupational dosimetry solutions that monitor radiation exposure of medical staff. This is the issuer’s Other product category within Medical.
medicalOtherRevenueRevenue from Mirion Medical, which supplies radiation therapy and diagnostic imaging quality assurance, nuclear medicine equipment, and occupational dosimetry services.
medicalRevenueRevenue attributed to Mirion sales sites in North America. Geography follows the originating site rather than the customer’s delivery location.
northAmericaRevenueRevenue from Mirion Nuclear & Safety products for the nuclear power plant lifecycle, including core detectors, measurement devices, monitoring and control, maintenance, decontamination and decommissioning equipment.
nuclearRevenueOperating income or loss of Mirion Nuclear & Safety used by management to evaluate the segment, including depreciation, amortization and applicable segment charges. Corporate costs and financing, tax and other non-operating items are excluded; historical comparisons use issuer-recast allocations.
nuclearSafetyOperatingIncomeRevenue from Mirion Nuclear & Safety products outside nuclear power and labs and research, primarily for industrial and defense applications. This is the issuer’s Other product category within Nuclear & Safety.
nuclearSafetyOtherRevenueRevenue from Mirion Nuclear & Safety, which supplies radiation detection, measurement and monitoring equipment for nuclear power, laboratories, research, industrial and defense applications. This segment was previously named Technologies and Industrial.
nuclearSafetyRevenueValue of Mirion customer contracts entered into during the period, comprising revenue earned in the period and revenue expected in future periods from those contracts. As-reported totals retain issuer de-bookings and include acquired businesses from their acquisition dates.
ordersTransaction price allocated to Mirion’s remaining performance obligations for open customer contracts at period end, representing committed but undelivered contracts and purchase orders. This is a balance of future contracted revenue, also described as backlog, rather than orders received during the period.
remainingPerformanceObligations